๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Factors affecting relapse following chemotherapy for Hodgkin's disease

โœ Scribed by J.R. Yarnold; A.M. Jelliffe; G. Vaughan Hudson

Book ID
117079781
Publisher
Elsevier Science
Year
1982
Tongue
English
Weight
248 KB
Volume
33
Category
Article
ISSN
0009-9260

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Combination chemotherapy for the treatme
Combination chemotherapy for the treatment of Hodgkin's disease in relapse
โœ David J. Straus; Jane Myers; Benjamin Koziner; Burton J. Lee; Bayard D. Clarkson ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› Springer ๐ŸŒ English โš– 558 KB

Vindesine (desacetyl vinblastine amide sulfate, DVA) was used in combination with CCNU (lomustine) and melphalan (Alkeran) (CAD) to treat 15 heavily pretreated patients with Hodgkin's disease in relapse. The patients were treated with up to six cycles, depending upon their response. Two patients (13

Gonadal function following chemotherapy
Gonadal function following chemotherapy for childhood Hodgkin's disease
โœ Mackie, E. J.; Radford, M.; Shalet, S. M. ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 452 KB ๐Ÿ‘ 2 views

Gonadal function was assessed in 101 postpubertal subjects after chemotherapy for childhood Hodgkin's disease. All had received ChlVPP (chlorambucil, vinblastine, procarbazine, and prednisolone) chemotherapy alone, with no radiotherapy below the diaphragm. Go- nadotropin levels were available in 46